Evaluation of late presentation for HIV treatment in a reference center in Belo Horizonte, Southeastern Brazil, from 2008 to 2010

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
Melissa Bianchetti ValentiniUnaí Tupinambás

Abstract

Since 1996 Brazil has provided universal access to free antiretroviral therapy, and as a consequence, HIV/AIDS patients' survival rate has improved dramatically. However, according to scientific reports, a significant number of patients are still late presenting for HIV treatment, which leads to consequences both for the individual and society. Clinical and immunological characteristics of HIV patients newly diagnosed were accessed and factors associated with late presentation for treatment were evaluated. A cross-sectional study was carried out in an HIV/AIDS reference center in Belo Horizonte, Minas Gerais, in Southeastern Brazil from 2008 to 2010. Operationally, patients with late presentation (LP) for treatment were those whose first CD4 cell count was less than 350 cells/mm(3) or presented an AIDS defining opportunistic infection. Patients with late presentation with advanced disease (LPAD) were those whose first CD4 cell count was less than 200 cells/mm(3) or presented an AIDS defining opportunistic infection. LP and LPAD associated risk factors were evaluated using logistic regression methods. Five hundred and twenty patients were included in the analysis. The median CD4 cell count was 336 cells/mm(3) (IQR: 130-531). Two...Continue Reading

References

Dec 4, 2002·AIDS·Guido Carlos Levi, Marco Antonio A Vitória
Apr 27, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keri N AlthoffRichard D Moore
Jun 22, 2010·HIV Medicine·A AntinoriUNKNOWN European Late Presenter Consensus Working Group
Jan 25, 2011·The Journal of the Association of Nurses in AIDS Care : JANAC·Gisella Souza PereiraSheila Araújo Teles
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Sep 1, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ronaldo I MoreiraRichard D Moore
Jan 6, 2012·AIDS and Behavior·Abraham MukoloKenneth A Wallston
May 23, 2012·AIDS Research and Human Retroviruses·Mauro Schechter, Antonio G Pacheco
Sep 27, 2012·Salud pública de México·Brenda Crabtree-RamírezJuan Sierra-Madero
Aug 8, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine R LeskoMichael J Mugavero
Oct 19, 2013·PLoS Medicine·Amanda MocroftUNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord

❮ Previous
Next ❯

Citations

Jul 5, 2018·Revista Da Sociedade Brasileira De Medicina Tropical·Priscila Valéria do Carmo CarvalhoUnai Tupinambás
Nov 2, 2019·American Journal of Epidemiology·Pablo F Belaunzarán-ZamudioUNKNOWN Caribbean, Central and South America network for HIV epidemiology (CCASAnet)
Sep 3, 2020·Revista latino-americana de enfermagem·Luana Carla Santana RibeiroFrancisco Carlos Félix Lana
May 14, 2019·Journal of Tropical Medicine·Priscila Ribeiro Guimarães PachecoMarília Dalva Turchi
Sep 10, 2020·Revista brasileira de enfermagem·Angélica da Mata RossiElma Mathias Dessunti
Jul 29, 2021·Revista brasileira de enfermagem·Luana Carla Santana RibeiroMirian Santos Paiva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.